Therapies, Investigational
"Therapies, Investigational" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Treatments which are undergoing clinical trials or for which there is insufficient evidence to determine their effects on health outcomes; coverage for such treatments is often denied by health insurers.
| Descriptor ID |
D035703
|
| MeSH Number(s) |
E02.931
|
| Concept/Terms |
Therapies, Investigational- Therapies, Investigational
- Investigational Therapy
- Therapy, Investigational
- Investigational Treatments
- Investigational Treatment
- Treatment, Investigational
- Treatments, Investigational
- Experimental Therapies
- Experimental Therapy
- Therapies, Experimental
- Therapy, Experimental
- Investigational Therapies
|
Below are MeSH descriptors whose meaning is more general than "Therapies, Investigational".
Below are MeSH descriptors whose meaning is more specific than "Therapies, Investigational".
This graph shows the total number of publications written about "Therapies, Investigational" by people in this website by year, and whether "Therapies, Investigational" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 2 | 2 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 3 | 0 | 3 |
| 2011 | 2 | 1 | 3 |
| 2012 | 1 | 1 | 2 |
| 2013 | 1 | 1 | 2 |
| 2014 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 2 | 3 |
| 2018 | 1 | 0 | 1 |
| 2019 | 2 | 1 | 3 |
| 2020 | 1 | 5 | 6 |
| 2021 | 2 | 1 | 3 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Therapies, Investigational" by people in Profiles.
-
Cutaneous T-Cell Lymphoma: Current and Emerging Therapies. Oncology (Williston Park). 2023 02 24; 37(2):55-62.
-
Novel Therapeutics in Radioactive Iodine-Resistant Thyroid Cancer. Front Endocrinol (Lausanne). 2021; 12:720723.
-
Professional integrity in maternal?- fetal innovation and research: an essential component of perinatal medicine. J Perinat Med. 2021 Nov 25; 49(9):1027-1032.
-
The times they are a-changin': Isn't it time to expand the trainee curriculum? Fertil Steril. 2021 01; 115(1):43-44.
-
Rate of change in investigational treatment options: An analysis of reports from a large precision oncology decision support effort. Int J Med Inform. 2020 11; 143:104261.
-
Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions. J Hematol Oncol. 2020 06 05; 13(1):70.
-
Competitive flow diversion of multiple P1 aneurysms: proposed classification. BMJ Case Rep. 2020 Jun 03; 13(6).
-
High-specific-activity iodine 131 metaiodobenzylguanidine for the treatment of metastatic pheochromocytoma or paraganglioma: a novel therapy for an orphan disease. Curr Opin Endocrinol Diabetes Obes. 2020 06; 27(3):162-169.
-
Performance of prognostic markers in the prediction of wound healing or amputation among patients with foot ulcers in diabetes: A systematic review. Diabetes Metab Res Rev. 2020 03; 36 Suppl 1:e3278.
-
EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2020 update on diagnosis, risk-stratification and management. Am J Hematol. 2020 04; 95(4):435-445.